This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
That's a very interesting reply, albeit from an 'alien' : ) I too have found it very difficult to find results of long term studies on the effects of Zoladex/Lupron, and many other treatments.
And, like many others, I read news of cyberknife treatment with some awe. Guess It's too easy to swallow all the 'hype'.
I never realised that the FDA had gone against Casodex in 150 doseage. In my own case, the oncologist immediately gave me Casodex 150 when I asked to come off Zoladex a year earlier than planned.
So far it seems his decision was the right one for me,
and if I had been limited to Casodex 100 then perhaps my outcome may have been far different.
Many thanks for all your efforts in keeping us abreast of happenings in the medical field, particularly in regard to PCa.
